Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
PBS docuseries puts KC creator at the intersection food and ‘transformational travel’
Food travel is about more than getting the most exotic or expensive social media-worthy photo of a meal to share for superficial clout, said Jim Kane, emphasizing the transformation power of connection when someone truly allows themselves to use food as a lens for understanding culture. “Before the pandemic, there were a lot of checklists…
A misstep ended their ‘Squid Game’ run together; the business of their friendship keeps moving
While not everything on reality TV is 100 percent … well, real, the bond between “Squid Game: The Challenge” competitors Stephen Lomas and Chase Higgins is anything but scripted, the Kansas City duo said. Longtime friends and business partners — the two previously co-founded Let’s Get Moving, a social media savvy moving company that gained…
How Kauffman Scholars’ 20-year run reflected the value of representation for Black, Brown students
Editor’s note: The Ewing Marion Kauffman Foundation is a financial supporter of Startland News. The legacy of Kauffman Scholars — an initiative of the Ewing Marion Kauffman Foundation that sunset earlier in 2023 after 20 years — can be seen in the decades of students impacted and the passion fueling the effort from within, according to a…
This hands-on video production workshop at DeLaSalle will put careers in focus
A new partnership between a Kansas City video production company and a charter school serving teens along the Troost corridor is expected to give DeLaSalle High School students a stronger entry point into an emerging industry, said Jasmine Nastasi. “It’s a way to help with recruiting, to streamline the process, and to have an official…